The challenge of eliciting opinions of gene therapy for SCD

Blood Adv. 2023 Dec 12;7(23):7369-7370. doi: 10.1182/bloodadvances.2023011606.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Genetic Therapy
  • Humans
  • Risk Assessment